|
Sep 28
|
Karuna Takes A Big Step In Schizophrenia Treatment. But Shares Yo-Yo.
|
|
Sep 28
|
Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia
|
|
Sep 22
|
What Makes Karuna Therapeutics (KRTX) a Prospective Investment?
|
|
Sep 12
|
Chief Medical Officer Stephen Brannan Sells 5,000 Shares of Karuna Therapeutics Inc (KRTX)
|
|
Jul 20
|
Karuna Therapeutics to Announce Second Quarter 2023 Financial Results and Provide General Business Update on Thursday, August 3, 2023
|